159 related articles for article (PubMed ID: 17961878)
21. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
22. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
23. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
[TBL] [Abstract][Full Text] [Related]
24. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
25. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF
J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708
[TBL] [Abstract][Full Text] [Related]
26. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
[TBL] [Abstract][Full Text] [Related]
27. Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.
Avogadri F; Merghoub T; Maughan MF; Hirschhorn-Cymerman D; Morris J; Ritter E; Olmsted R; Houghton AN; Wolchok JD
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844763
[TBL] [Abstract][Full Text] [Related]
28. Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs.
Démoulins T; Ruggli N; Gerber M; Thomann-Harwood LJ; Ebensen T; Schulze K; Guzmán CA; McCullough KC
Front Immunol; 2020; 11():622385. PubMed ID: 33584723
[TBL] [Abstract][Full Text] [Related]
29. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
Johansson BE
Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
[TBL] [Abstract][Full Text] [Related]
30. A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.
Durso RJ; Andjelic S; Gardner JP; Margitich DJ; Donovan GP; Arrigale RR; Wang X; Maughan MF; Talarico TL; Olmsted RA; Heston WD; Maddon PJ; Olson WC
Clin Cancer Res; 2007 Jul; 13(13):3999-4008. PubMed ID: 17606734
[TBL] [Abstract][Full Text] [Related]
31. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V; Canitano A; Temperton N; Castrucci MR; Salvatore M; Michelini Z; Cara A; Negri D
Front Immunol; 2018; 9():171. PubMed ID: 29459873
[TBL] [Abstract][Full Text] [Related]
32. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
Sylte MJ; Hubby B; Suarez DL
Vaccine; 2007 May; 25(19):3763-72. PubMed ID: 17350145
[TBL] [Abstract][Full Text] [Related]
33. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.
Hooper JW; Ferro AM; Golden JW; Silvera P; Dudek J; Alterson K; Custer M; Rivers B; Morris J; Owens G; Smith JF; Kamrud KI
Vaccine; 2009 Dec; 28(2):494-511. PubMed ID: 19833247
[TBL] [Abstract][Full Text] [Related]
34. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
[TBL] [Abstract][Full Text] [Related]
35. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
Yoshikawa T; Suzuki Y; Nomoto A; Sata T; Kurata T; Tamura Si
Vaccine; 2002 Nov; 21(1-2):60-6. PubMed ID: 12443663
[TBL] [Abstract][Full Text] [Related]
36. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
[TBL] [Abstract][Full Text] [Related]
37. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.
Bright RA; Carter DM; Crevar CJ; Toapanta FR; Steckbeck JD; Cole KS; Kumar NM; Pushko P; Smith G; Tumpey TM; Ross TM
PLoS One; 2008 Jan; 3(1):e1501. PubMed ID: 18231588
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ
Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model.
Chepkwony S; Parys A; Vandoorn E; Chiers K; Van Reeth K
Viruses; 2020 Sep; 12(9):. PubMed ID: 32882956
[TBL] [Abstract][Full Text] [Related]
40. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]